Home › ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product
 

Keywords :   


ZOSTAVAX (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product

2013-10-23 13:30:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that ZOSTAVAX (Zoster Vaccine Live), the company's vaccine to help prevent shingles, received the Prix Galien USA 2013 Award for Best Biotechnology Product. Language: English Contact: Media:MerckCaroline Lappetito, (267) 305-7639 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: product usa live prix

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »